Clinical Trial Update: Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 safety study evaluating injections of proinsulin peptide to slow autoimmune destruction of insulin-producing cells in people newly diagnosed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Proinsulin peptide injections (proinsulin peptide)

Snippet

Sponsor: Cardiff University | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: COMPLETED